Supernus Pharmaceuticals, Inc. (SUPN)
49.77
-0.23
(-0.46%)
USD |
NASDAQ |
Jan 20, 12:32
Supernus Pharmaceuticals EPS Diluted (Quarterly): -0.7978 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amphastar Pharmaceuticals, Inc. | 0.3639 |
| BridgeBio Pharma, Inc. | -0.9525 |
| Catalyst Pharmaceuticals, Inc. | 0.4153 |
| Assembly Biosciences, Inc. | -0.7249 |
| Viking Therapeutics, Inc. | -0.8083 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -45.12M |
| Revenue (Quarterly) | 192.10M |
| Total Expenses (Quarterly) | 237.22M |
| Enterprise Value | 2.628B |
| Gross Profit Margin (Quarterly) | 77.20% |
| Profit Margin (Quarterly) | -23.49% |
| Earnings Yield | -0.68% |
| Normalized Earnings Yield | -0.5827 |